Effects of empagliflozin on left ventricular diastolic function in addition to usual care in individuals with type 2 diabetes mellitus : results from the randomized, double-blind, placebo-controlled EmDia trial

Prochaska, Jürgen H.Jünger, ClausSchulz, AndreasArnold, NatalieMüller, FelixHeidorn, Marc WilliamBaumkötter, RiekeZahn, DanielaKoeck, ThomasTröbs, Sven-OliverLackner, Karl J.Daiber, AndreasBinder, HaraldShah, Sanjiv J.Gori, TommasoMünzel, ThomasWild, Philipp S.2023-05-032023-05-032023https://openscience.ub.uni-mainz.de/handle/20.500.12030/9060engCC-BY-4.0https://creativecommons.org/licenses/by/4.0/610 Medizin610 Medical sciencesEffects of empagliflozin on left ventricular diastolic function in addition to usual care in individuals with type 2 diabetes mellitus : results from the randomized, double-blind, placebo-controlled EmDia trialZeitschriftenaufsatz